IP Library Granted Patent US 7,223,833
Granted Patent B1
US 7,223,833 · App. 08/319,411 · Granted May 29, 2007

Peptide nucleic acid conjugates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,223,833
App. No.
08/319,411
Granted
May 29, 2007
Kind
B1
Abstract

A novel class of peptide nucleic acids are described which include a conjugate attached thereto. The peptide nucleic acids generally comprise ligands such as naturally occurring DNA bases attached to a peptide backbone through a suitable linker.

Claims (16)

1. A peptide nucleic acid of the formula:

wherein:

m is an integer from 1 to about 50;

L and L m independently are naturally occurring nucleobases;

C and C m are (CR 6 R 7 ) y ; wherein:

R 6 and R 7 are hydrogen;

R 3 is hydrogen;

D and D m are (CR 6 R 7 ) z ;

y is 1 and z is 2;

G m is —NR 3 CO— in either orientation;

each pair of A-A m and B-B m are >N—C(O)—CH 2 —;

I is —NR 8 R 9 or —NR 10 C(O)R 11 ; wherein:

R 8 , R 9 , R 10 and R 11 independently are hydrogen, alkyl, an amino protecting group, a reporter ligand, an intercalator, a chelator, a peptide, a protein, a carbohydrate, a lipid, a steroid, a nucleoside, a nucleotide, a nucleotide diphosphate, a nucleotide triphosphate, an oligonucleotide, an oligonucleoside, a soluble polymer, a non-soluble polymer, a reporter enzyme, a reporter molecule, a terpene, a phospholipid, a cell receptor binding molecule, a water soluble vitamin, a lipid soluble vitamin, an RNA/DNA cleaving complex, a porphyrin, or a polymeric compound selected from polymeric amines, polymeric glycols and polyethers; and

Q is —CO 2 H, —CO 2 R 8 , or —CONR 8 R 9 .

2. The peptide nucleic acid of claim 1 wherein R 8 , R 9 , R 10 and R 11 independently are hydrogen, alkyl, a peptide, a protein, a carbohydrate, a nucleoside, a nucleotide, a nucleotide diphosphate, a nucleotide triphosphate, an oligonucleotide, or an oligonucleoside.

3. The peptide nucleic acid of claim 1 wherein R 8 , R 9 , R 10 and R 11 independently are a nucleoside, a nucleotide, an oligonucleotide, or an oligonucleoside.

Assignments (3)
CHANGE OF NAME Recorded Jul 26, 2017
From: ISIS PHARMACEUTICALS, INC.
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 043341/0557 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 1999
From: SONNICHSEN, SOREN HOLST; LOHSE, JESPER
To: NIELSEN, PETER
Reel/Frame 009985/0840 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 1999
From: MANOHARAN, MUTHIAH; KIELY, JOHN; GRIFFITH, MICHAEL; SPRANKLE, KELLY
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 009988/0264 →